Fluorescence diffuse optical tomography provides high contrast, 3-D look at breast cancer

Researchers at the University of Pennsylvania have created the first three-dimensional optical images of human breast cancer in patients based on tissue fluorescence.

Fluorescence diffuse optical tomography, or FDOT, relies on the presence of fluorophore molecules in tissue that re-radiate fluorescent light after illumination by excitation light of a different color. The reconstructed images demonstrated significant tumor contrast compared to typical endogenous optical contrast in breast. Tumor-to-normal tissue contrast based on FDOT with the fluorophore Indocyanine Green, or ICG, was two-to-four-fold higher than contrast based on endogenous contrasts such as hemoglobin and scattering parameters obtained with traditional diffuse optical tomography, or DOT.

With the continued development of molecularly-targeted exogenous fluorophores, the research helps pave the way for diagnostic tools based on optics that will provide improved sensitivity and specificity between healthy and normal tissues.

Fluorophores are exquisitely sensitive to their local environment, and therefore FDOT holds potential to provide information about tumor physiology, including tissue oxygen, tissue pH and tissue calcium concentration levels.

“Previously, the FDOT technique was used for in-vivo imaging of animal tissues, but ours is the first successful demonstration of its use to detect cancer in deep-tissue, human breast imaging,” Arjun Yodh, professor of physics at Penn, said.

DOT uses near-infrared light to scan and provide cross-sectional and volumetric views of biological tissue. It is promising as a tool to characterize lesions and monitor therapy; however, its resolution is not as high as other anatomically oriented imaging modalities, and contrast comes mainly from vasculature abnormalities.

In the current study using FDOT, the intravenous addition of an exogenous molecular agent, ICG, was used to enhance tumor contrast. The vasculature of tumors delays ICG washout from the body and thereby elevates its concentration in tumors relative to normal tissue. Penn researchers plan to improve the instrument in order to assess the flourophore lifetime which will provide richer information about tumor physiology.

“The potential uses of optical fluorophores bear close resemblance to the use of contrast agents in PET and MRI,” Yodh said. “Successful FDOT represents a critical first step towards application of molecular imaging probes such as dyes and molecular beacons that bind to tumor-specific receptors in deep tissue, a current direction for biomedical optics research.”

Penn researchers accomplished fluorescence excitation and detection in the soft-compression, parallel-plane, transmission geometry using laser sources at 786 nm and spectrally filtered CCD detection.

Source: University of Pennsylvania

Related stories:

New stem cell tools to aid drug development
SCIENTISTS have designed, developed and tested new molecular tools for stem cell research to direct the formation of certain tissue types for use in drug development programmes.
Battling diabetes with beta cells
Affecting eight percent of America's population, diabetes can lead to blindness, kidney failure, strokes and heart disease. Thanks to Tel Aviv University researchers, a new cure –– based on advances in cell therapy –– may be within reach.
Tiny 3-D ultrasound probe guides catheter procedures
An ultrasound probe small enough to ride along at the tip of a catheter can provide physicians with clearer real-time images of soft tissue without the risks associated with conventional x-ray catheter guidance.
Research aims to put tongues in control of devices
(AP) -- The tireless tongue already controls taste and speech, helps kiss and swallow and fights germs. Now scientists hope to add one more ability to the mouthy muscle, and turn it into a computer control pad.
Senescence in liver cells can provoke a beneficial immune reaction
Although post-reproductive life in humans is often associated with decline and a loss of powers, an analogous state in certain cells -- called senescence -- is proving to be one of ironic potency. Scientists at Cold Spring Harbor Laboratory (CSHL) today reported that a particular class of senescent liver cells orchestrates a sequence of events in living mice that can limit fibrosis, a natural response of the liver to acute damage.
Carnegie Mellon MRI technology that non-invasively locates, quantifies specific cells in the body
Magnetic resonance imaging (MRI) isn't just for capturing detailed images of the body's anatomy. Thanks to novel imaging reagents and technology developed by Carnegie Mellon University scientist Eric Ahrens, MRI can be used to visualize — with "exquisite" specificity — cell populations of interest in the living body. The ability to non-invasively locate and track cells, such as immune cells, will greatly aid the study and treatment of cancer, inflammation, and autoimmune diseases, as well as provide a tool for advancing clinical translation of the emerging field of cellular regenerative medicine, by tracking stem cells for example.
Joslin study identifies protein that produces 'good' fat
A study by researchers at the Joslin Diabetes Center has shown that a protein known for its role in inducing bone growth can also help promote the development of brown fat, a "good" fat that helps in the expenditure of energy and plays a role in fighting obesity.
Brain surgery is getting easier on patients
Dr. Edward Duckworth is part of a new generation of neurosurgeons who are making brain surgery a lot easier on patients. At Loyola University Hospital, Duckworth is using less-invasive techniques to remove tumors, to repair life-threatening aneurysms and to dramatically reduce seizures in epilepsy patients.

News discussion:

Medicine & Health news